{"id":12056,"date":"2015-02-27T11:13:28","date_gmt":"2015-02-27T10:13:28","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=12056"},"modified":"2015-02-27T11:13:28","modified_gmt":"2015-02-27T10:13:28","slug":"cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/","title":{"rendered":"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca?"},"content":{"rendered":"<p>Segons l\u2019Organitzaci\u00f3 Mundial de la Salut (OMS), <b>la malaltia cardiovascular \u00e9s la causa m\u00e9s important de mort a tot el m\u00f3n i encara est\u00e0 en ascens.<\/b>\u00a0La intervenci\u00f3 dels professionals en la prevenci\u00f3 de\u00a0la s\u00edndrome coron\u00e0ria aguda (SCA) i la insufici\u00e8ncia card\u00edaca (IC), la reducci\u00f3 dels factors de risc cardiovascular i la millora de l\u2019adher\u00e8ncia als tractaments, ha redu\u00eft significativament la mortalitat cardiovascular. Malgrat tot, les dades d\u2019estudis recents mostren que un de cada sis pacients amb SCA mor durant el primer any despr\u00e9s d\u2019haver sofert un primer episodi.<\/p>\n<p>Per con\u00e8ixer cap a on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca, saber quins s\u00f3n els nous reptes cl\u00ednics i terap\u00e8utics i aprofundir en el coneixement dels tractaments farmacol\u00f2gics des del maneig inicial fins a l\u2019atenci\u00f3 prim\u00e0ria, el Col\u00b7legi va organitzar el curs \u201cActualitzaci\u00f3 en la s\u00edndrome coron\u00e0ria aguda i la insufici\u00e8ncia card\u00edaca\u201d per a farmac\u00e8utics d\u2019atenci\u00f3 prim\u00e0ria, d&#8217;hospitals i comunitaris. Va tenir lloc el 12 de febrer.<\/p>\n<p style=\"text-align: center;\"><img fetchpriority=\"high\" decoding=\"async\" class=\" wp-image-12057 aligncenter\" alt=\"curs-sindrome-coronaria (1)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/02\/curs-sindrome-coronaria-1.jpg\" width=\"509\" height=\"243\" \/><\/p>\n<p><a href=\"http:\/\/www.portalfarma.com\/Profesionales\/Notas-de-prensa\/Paginas\/Comunicado-Organizacion-Farmaceutica-Colegial-Distribucion-ilegal-de-medicamentos.aspx\" target=\"_blank\" rel=\"noopener\"><div class=\"box shadow\"><\/a>\u201cUn curs interessant i controvertit des del punt de vista del debat sobre el rol que ha de tenir cada nivell assistencial en el seguiment d\u2019aquest tipus de pacients i al mateix temps molt enriquidor al comptar amb la pres\u00e8ncia de farmac\u00e8utics de tots els \u00e0mbits assistencials\u201d, explica<b> Roser Vall\u00e8s, vocal d\u2019Atenci\u00f3 Prim\u00e0ria del COFB i coordinadora del curs.<\/b><\/div><\/p>\n<p>Aquesta formaci\u00f3, que es va poder cursar presencialment i online amb el suport Webinar (va ser retransmesa en paral\u00b7lel a la sessi\u00f3 presencial per mitj\u00e0 d\u2019Internet) va ser una reflexi\u00f3 conjunta amb diferents especialistes amb punts de vista diversos sobre la cl\u00ednica i la terap\u00e8utica farmacol\u00f2gica de la s\u00edndrome coron\u00e0ria aguda i la insufici\u00e8ncia card\u00edaca.<\/p>\n\n<p><b>Lina <\/b><b>Badim\u00f3n<\/b>, farmac\u00e8utica i metgessa especialista i directora del Centre d\u2019Investigaci\u00f3 Cardiovascular (CSIC-ICCC), Centre Mixte del Consell Superior de Investigacions Cient\u00edfiques (CSIC) i l\u2019Institut Catal\u00e0 de Ci\u00e8ncies Cardiovasculars (ICCC) a l\u2019Hospital de la Santa Creu i Sant Pau-UAB, i el <b>Antoni Bay\u00e9s<\/b>, president de la Societat de Cardiologia i Director de Servei de Cardiologia de l\u2019Hospital Germans Trias i Pujol de Badalona, van oferir, per una banda, una xerrada sobre les novetats en qu\u00e8 s\u2019est\u00e0 treballant actualment en l\u2019abordatge farmacol\u00f2gic de la s\u00edndrome coron\u00e0ria aguda i quines s\u00f3n les l\u00ednies de futur en la recerca de tractaments que millorin el pron\u00f2stic d\u2019aquest problema de salut. D&#8217;altra banda, el Dr. Bay\u00e9s va presentar un<strong> nou model d\u2019organitzaci\u00f3 multidisciplinar, coordinat des de l\u2019hospital, per millorar l\u2019atenci\u00f3 sanit\u00e0ria als pacients amb insufici\u00e8ncia card\u00edaca, i on \u00e9s fonamental la coordinaci\u00f3 i la integraci\u00f3 amb l\u2019activitat assistencial de l\u2019atenci\u00f3 prim\u00e0ria i de l&#8217;oficina de farm\u00e0cia<\/strong>. Tots dos van aportar idees noves en el maneig d\u2019aquestes dues patologies, des del punt de vista de la recerca i de l\u2019\u00e0mbit hospitalari, que van ajudar a que els assistents es fessin una idea de quin ser\u00e0 el futur en l\u2019abordatge terap\u00e8utic d\u2019aquestes dues patologies.<\/p>\n<figure id=\"attachment_12059\" aria-describedby=\"caption-attachment-12059\" style=\"width: 306px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/02\/curs-sindrome-coronaria-3.jpg\"><img decoding=\"async\" class=\" wp-image-12059\" alt=\"curs-sindrome-coronaria (3)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/02\/curs-sindrome-coronaria-3.jpg\" width=\"306\" height=\"204\" \/><\/a><figcaption id=\"caption-attachment-12059\" class=\"wp-caption-text\">D&#8217;esquerra a dreta, Antoni Bay\u00e9s, Roser Vall\u00e8s, Lina Badim\u00f3n, Ana M. de Andr\u00e9s i Natalia L\u00f3pez<\/figcaption><\/figure>\n<p>En la segona part del curs, <b>Ana M. de Andr\u00e9s<\/b>, farmac\u00e8utica especialista en farm\u00e0cia hospital\u00e0ria que treballa a l\u2019\u00c0mbit d\u2019Avaluaci\u00f3 de Farm\u00e0cia de l\u2019Ag\u00e8ncia de Qualitat i Avaluaci\u00f3 Sanit\u00e0ries de Catalunya (AQuAS), i <b>Natalia L\u00f3pez<\/b>, metgessa de fam\u00edlia de l\u2019EAP Congr\u00e9s-CS Maragall SAP Dreta &#8211; Barcelona Ciutat, van explicar quines s\u00f3n les recomanacions actuals en el maneig farmacol\u00f2gic d\u2019aquestes dues patologies, s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca, sobretot en l\u2019\u00e0mbit de l\u2019atenci\u00f3 prim\u00e0ria. Tamb\u00e9 van ajudar a aclarir aspectes controvertits en la selecci\u00f3 de les millors opcions terap\u00e8utiques actuals tenint en compte la qualitat i la seguretat d\u2019aquestes opcions.<\/p>\n<p align=\"right\"><b>Amb el patrocini de:<\/b><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"http:\/\/www.astrazeneca.es\/inicio\/\" target=\"_blank\" rel=\"noopener\"><\/p>\n<p align=\"right\"><img decoding=\"async\" class=\"size-full wp-image-6822 alignright\" alt=\"astrazeneca_logo\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/06\/astrazeneca_logo.jpg\" width=\"150\" height=\"36\" \/><\/p>\n<p><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Segons l\u2019Organitzaci\u00f3 Mundial de la Salut (OMS), la malaltia cardiovascular \u00e9s la causa m\u00e9s important de mort a tot el m\u00f3n i encara est\u00e0 en ascens.\u00a0La intervenci\u00f3 dels professionals en la prevenci\u00f3 de\u00a0la s\u00edndrome coron\u00e0ria aguda (SCA) i la insufici\u00e8ncia card\u00edaca (IC), la reducci\u00f3 dels factors de risc cardiovascular i [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":12057,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[938,70],"class_list":["post-12056","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-atencio-primaria","tag-formacio"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca? - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca? - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Segons l\u2019Organitzaci\u00f3 Mundial de la Salut (OMS), la malaltia cardiovascular \u00e9s la causa m\u00e9s important de mort a tot el m\u00f3n i encara est\u00e0 en ascens.\u00a0La intervenci\u00f3 dels professionals en la prevenci\u00f3 de\u00a0la s\u00edndrome coron\u00e0ria aguda (SCA) i la insufici\u00e8ncia card\u00edaca (IC), la reducci\u00f3 dels factors de risc cardiovascular i [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-02-27T10:13:28+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca?\",\"datePublished\":\"2015-02-27T10:13:28+00:00\",\"dateModified\":\"2015-02-27T10:13:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/\"},\"wordCount\":739,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 prim\u00e0ria\",\"Formaci\u00f3\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/\",\"name\":\"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca? - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2015-02-27T10:13:28+00:00\",\"dateModified\":\"2015-02-27T10:13:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/","og_locale":"ca_ES","og_type":"article","og_title":"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"Segons l\u2019Organitzaci\u00f3 Mundial de la Salut (OMS), la malaltia cardiovascular \u00e9s la causa m\u00e9s important de mort a tot el m\u00f3n i encara est\u00e0 en ascens.\u00a0La intervenci\u00f3 dels professionals en la prevenci\u00f3 de\u00a0la s\u00edndrome coron\u00e0ria aguda (SCA) i la insufici\u00e8ncia card\u00edaca (IC), la reducci\u00f3 dels factors de risc cardiovascular i [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2015-02-27T10:13:28+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"4 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca?","datePublished":"2015-02-27T10:13:28+00:00","dateModified":"2015-02-27T10:13:28+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/"},"wordCount":739,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 prim\u00e0ria","Formaci\u00f3"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/","url":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/","name":"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#primaryimage"},"thumbnailUrl":"","datePublished":"2015-02-27T10:13:28+00:00","dateModified":"2015-02-27T10:13:28+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca?"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Segons l\u2019Organitzaci\u00f3 Mundial de la Salut (OMS), la malaltia cardiovascular \u00e9s la causa m\u00e9s important de mort a tot el m\u00f3n i encara est\u00e0 en ascens.\u00a0La intervenci\u00f3 dels professionals en la prevenci\u00f3 de\u00a0la s\u00edndrome coron\u00e0ria aguda (SCA) i la insufici\u00e8ncia card\u00edaca (IC), la reducci\u00f3 dels factors de risc cardiovascular i [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/12056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=12056"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/12056\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=12056"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=12056"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=12056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}